Vericel Corporation (VCEL): Price and Financial Metrics

VCEL POWR Grades

• Quality is the dimension where VCEL ranks best; there it ranks ahead of 72.35% of US stocks.
• The strongest trend for VCEL is in Growth, which has been heading up over the past 179 days.
• VCEL's current lowest rank is in the Sentiment metric (where it is better than 10.46% of US stocks).

VCEL Stock Summary

• The price/operating cash flow metric for VERICEL CORP is higher than 95.3% of stocks in our set with a positive cash flow.
• With a price/sales ratio of 9.67, VERICEL CORP has a higher such ratio than 89.03% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.4 for VERICEL CORP; that's greater than it is for merely 22.14% of US stocks.
• Stocks that are quantitatively similar to VCEL, based on their financial statements, market capitalization, and price volatility, are TNON, YOU, FLGT, FTCI, and SVFD.
• VCEL's SEC filings can be seen here. And to visit VERICEL CORP's official web site, go to vcel.com.

VCEL Valuation Summary

• In comparison to the median Healthcare stock, VCEL's price/sales ratio is 350% higher, now standing at 9.9.
• Over the past 243 months, VCEL's price/earnings ratio has gone down 93.1.

Below are key valuation metrics over time for VCEL.

VCEL Growth Metrics

The 4 year net cashflow from operations growth rate now stands at 87.81%.
• Its 3 year net cashflow from operations growth rate is now at 3481.9%.
• Its year over year price growth rate is now at -45.13%.

The table below shows VCEL's growth in key financial areas (numbers in millions of US dollars).

VCEL's Quality Factors

• VCEL has a Quality Grade of C, ranking ahead of 72.89% of graded US stocks.
• VCEL's asset turnover comes in at 0.761 -- ranking 35th of 682 Pharmaceutical Products stocks.
• TCON, NMTR, and PTCT are the stocks whose asset turnover ratios are most correlated with VCEL.

The table below shows VCEL's key quality metrics over time.